PTC Therapeutics (BH3.F) Q1 2026 Earnings

19FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.42
2
5.43
8.85

Details

Expected EPS
0.0876069936
Actual EPS
-1.418331
Surprise EPS
-1.51
Surprise Percent
+1,718.97%

Description

PTC Therapeutics (BH3.F) has reported earnings of -1.418331 per share for Q1 2026.

0 Comments

Share your thoughts